Evaxion Biotech is expected to report a significant decrease in EPS for Q4 2024.

From Nasdaq Inc.: 2025-03-31 16:00:00

Evaxion Biotech A/S (EVAX) is set to report earnings on 04/01/2025 for the quarter ending December 31, 2024. Analysts predict an earnings per share of $-0.03, a significant decrease from the $-0.8 reported in the same quarter last year, marking a -96.25% change. Check the full earnings calendar on Nasdaq’s website.



Read more at Nasdaq Inc.:: Pre-Market Earnings Report for April 1, 2025 : EVAX